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Background/aim: Mesenchymal stem cells (MSCs) are a type of adult stem cell consisting of a heterogeneous subset of stromal stem
cells that can be isolated from adult tissues. Folic acid is another important contributor to tissue regeneration and repair, which affects
the synthesis of some building block molecules used for wound healing. In this study, we examine the effect of folic acid and MSCderived soluble factors in the wound healing model.
Materials and methods: Human umbilical vein endothelial cells (HUVECs) and bone marrow-derived MSCs (BMSCs) were cultured
for this study. Cell proliferation analysis was done with xCELLigence RTCA. After 48 h of cultivation, the cell culture medium was
collected as MSC conditional medium containing mesenchymal stem cell-derived soluble factors (MDFs). Different concentrations of
MDFs (12%, 25%, 50%, 75%, and 100%) were applied to the HUVEC cell line. Folic acid (25, 30, 50, 60, 75, 90, and 100 µM) was tested
by application of three different groups (control, 25 µM folic acid, 625 µM folic acid inhibitors) for proliferation on the HUVEC cell line.
The combined effects of folic acid and MDFs were tested on the HUVEC cell line with 25 µM folic acid and 50 µM MDFs. All data were
statistically analyzed using SPSS 15.0 for Windows.
Results: Significant differences were observed between controls and cells treated with folic acid, as well as between controls and both
folic acid and MDFs (P < 0.05). Among the treated groups, the fastest wound closure rate was seen in cells treated with both folic acid
and MDFs.
Conclusion: The results show that both folic acid and MDFs increased the wound healing rate in HUVECs when they were used separately. The strongest benefits were seen in treatment using folic acid and MDFs together.
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1. Introduction
Wound healing is an important and complicated process
that involves cell proliferation, migration, angiogenesis,
reepithelization, and tissue remodeling as a result of
complex interactions between growth factors, extracellular
matrix molecules, and cells [1]. Stem cells have emerged
as a promising treatment for wounds due to their ability
to renew and differentiate themselves. Adult stem cells
such as bone marrow-derived mesenchymal stem cells
(BMSCs) and adipose-derived mesenchymal stem cells
(ASCs) are not hard to obtain due to ethical concerns and
availability like embryonic stem cells. BMSCs and ASCs
can be easily isolated in adults [2,3].

Mesenchymal stem cells (MSCs), a heterogeneous
subset of stromal stem cells, are multipotent adult stem cells
that are present in multiple tissues, including the umbilical
cord, bone marrow, and fat tissue. They are reproducible
and have a high potential for use in different areas [4].
Because of their stromal origin, they are supportive and
durable.
MSCs have the potential to differentiate into different
cell types primarily in connective tissue when provided
with appropriate microenvironmental conditions [5].
They have osteogenic, adipogenic, chondrogenic, and
myogenic differentiation capacities in in vitro conditions
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with appropriate stimuli. MSCs can also transform into
pancreatic beta cells, hepatocytes, endothelium, and
epithelioid cells [6]. MSC differentiation is a process that
involves the release of mesenchymal stem cell-derived
soluble factors (MDFs). MDFs are rich in materials that
are key substances in wound healing, including growth
factors such as transforming growth factor (TGF-β),
platelet-derived growth factor (PDGF), keratinocyte
growth factor (KGF), vascular endothelial growth factor
(VEGF), epidermal growth factor (EGF), fibroblast
growth factor (FGF), connective tissue growth factor
(CTGF), insulin-like growth factor (IGF), and colonystimulating factors (CSFs); cytokines such as tumor
necrosis factor α (TNF-α), interleukin-1, interleukin-6,
interleukin-8, and the angioinflammatory interleukins
(interleukin-4 and interleukin-10); and interferons [7].
MSCs interact with the innate and adaptive immune
system, causing the modulation of many effector
functions. Whenever tissue damage occurs, these stem
cells move to the area and start to repair the damage
[8,9]. They prevent the release of proinflammatory
cytokines and induce peripheral tolerance to promote
the survival of damaged cells [10]. Preclinical and
clinical studies suggest that transplanted MSCs alter
the phenotype. How immune cells function is largely
due to the production of MDFs. The expression varies
depending on the pathologic conditions to which MSCs
are exposed [11].
Folic acid is a water-soluble vitamin in the B complex
that requires exogenous uptake for health, growth, and
development. It is required as the precursor of cofactors
for single-carbon donors in the synthesis of DNA bases
and some other essential biomolecules [12]. It is involved
in many metabolic functions, including DNA replication
and repair, methylation, and synthesis of nucleotides and
some amino acids.
Folic acid, which is one of the important factors in
tissue regeneration and repair, is being investigated
due to its role in the synthesis of both building-block
molecules and their effects on differentiation [13].
Folic acid induces the differentiation of neural stem
cells into neurons via DNA methyltransferases and
plays an important role in stem cell proliferation and
differentiation [14]. In this study, the capacity of MSCs
to secrete endothelial damage by folic acid as a result of
coculture was investigated in an in vitro wound healing
model.
2. Materials and methods
2.1. Cell culture
Human umbilical vein endothelial cells (HUVECs)
(ATCC CRL-1730) were obtained from the American
Type Culture Collection (Rockville, MD, USA) and

cultured in low-glucose Dulbecco’s Modified Eagle’s
Medium (DMEM) containing 10% fetal bovine serum
(FBS, Cegrogen Biotech GmbH, Stadtallendorf,
Germany) and 1% penicillin/streptomycin (Biochrom
GmbH, Berlin, Germany). Cells were incubated at 37 °C
in 5% CO2 in humidified air.
BMSCs were cultured in Mesenchymal Stem Cell
Basal Medium for Adipose, Umbilical and Bone Marrowderived MSCs (ATCC PCS-500-030), containing 10%
FBS (Biochrom GmbH), 1% penicillin/streptomycin
(Biochrom GmbH), and L-glutamine (4.5 mM)
(Biochrom GmbH). Cells were incubated at 37 °C in 5%
CO2 in humidified air.
2.2. Cell proliferation and wound healing assay
The cells were incubated in the appropriate medium for
cell proliferation analysis with the xCELLigence RTCA
real-time cell analyzer. HUVECs were seeded at 5000
cells per well in 96-well culture plates. Cell index-cell
content (CI) values were recorded every 15 min for 48
h. The wells containing DMEM were used as negative
controls for resistivity baseline measurements.
After cell proliferation analysis, cells were seeded
at 105 cells per well in 6-well culture plates. When they
became confluent, a wound was created with a 200 µL
pipette. Different concentrations of folic acid (25, 30, 50,
60, 75, 90, 100 µM) were added into the wells. Cells were
incubated at 37 °C and 5% CO2 in humidified air. Images
of wound closure were taken at 0, 24, and 48 h using the
JuLI Br live cell movie analyzer (NanoEnTek, Korea)
with barrels attached. The amount of wound closure was
calculated with ImageJ software 1.49.
2.3. Coculture modeling and MDF production
protocols
The HUVEC cell line was plated on Matrigel in a 2-well
culture well. L-DMEM medium was added to the
upper chamber. The BMSC cell line was seeded in the
bottom chamber at 37 °C in 5% CO2 for 48 h. As a test
variable, folic acid was applied to the bottom chamber.
After 48 h, the cell-culture medium was collected as
MSC culture medium) containing MDFs and stored at
–80 °C. Different concentrations of this medium (12%,
25%, 50%, 75%, and 100%) were tested for proliferation
in the HUVEC cell line. Wound healing and combined
effects were based on EC50 dose. After another 48 h, the
stem cells in the lower chamber were observed under an
inverted microscope.
2.4. Statistical analysis
SPSS 15.0 (SPSS Inc., Chicago, IL, USA) was used for
the data analysis. The mean ± standard error (SE) was
used for numerical values found in the figures and
text. A nonparametric Mann–Whitney U test was used
to determine the statistical significance. P < 0.05 was
considered statistically signiﬁcant.
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3. Results
3.1. HUVEC cell line proliferation assays
Folic acid increased cell proliferation in the HUVEC cell
line. In this study, according to the analysis of the results
by the xCELLigence RTCA device, the cell index was used
to determine the EC50 dose as 50 µL (25% concentration)
as shown in Figure 1.
In order to determine the nontoxic doses of folic acid
inhibitors in the HUVEC cell line, proliferation studies
were performed with low and high doses according to the
literature [15]. Experiments were performed at 7 different
concentrations in each dose range. The highest nontoxic
HUVEC cell line for both inhibitors was 5 mM as shown
in Figure 2.
The proliferative effect of folic acid is blocked in the
HUVEC cell line by the combination of PMX and MTX,
an antagonist and an inhibitor of folic acid, respectively.
The proliferative effect was potentiated by the mediators
released into the coculture medium as defined in the MDF
production protocol and increased proliferation. Figure 3
shows the time-dependent effect of cell proliferation.
3.2. Wound healing
3.2.1. Folic acid effect
In the in vitro endothelial wound model of the HUVEC
cell line, the effects of folic acid were investigated, which
is a factor of the effects of MSCs, folic acid, and MDFs on
the environment.

In the wound healing model, an EC50 dose of folic
acid was used. Wound healing was measured at 0, 6, 12,
and 24 h as shown in Figure 4. The wound healing rate
was calculated as percentage motility index. After 24 h, the
motility index was 73.64% in the cell culture medium as a
control, 100% in the folic acid group, 63.82% in the folic
acid combined with MTX group, and 69.95% in the folic
acid combined with PTX group.
3.2.2. Mesenchymal stem cell-derived soluble factor
effect
In the wound healing model, a 25 µM dose of folic acid,
which increased the cell proliferation by 50%, and MDFs
(50 µL) obtained from MSC conditional medium and 25
µM folic acid-added MDFs (50 µL) in the coculture model
were selected. Wound healing was observed at 0, 6, 12, and
24 h. Wound healing rate was calculated as percentage
motility index. As shown in Figure 5, after 24 h, wound
healing with MDFs in the coculture model was calculated
as 83.74%, It was 100% in the folic acid group and 100%
in the group with folic acid combined with MSCs. After
12 h, wound healing was 67.30%, 89.56%, and 95.12%,
respectively.
Wound healing rate increases with the addition of
MDFs. In the positive control group with high FBS (20%),
the closure rate of 73.64% after 24 h increased to 83.74%
with the effect of MSCs. MDFs obtained by the addition of
folic acid to the coculture medium further increased the
wound healing rate in response to the folic acid.

Figure 1. Folic acid proliferation analysis. Cell proliferations were measured in real time for 48 h in the studied concentration range of
folic acid (2.5–100 µM). Cell index (CI), which is the change in the electrical impedance of the cell increase, is graphed against time.
When the trend change between recurrent measurements was analyzed using Mauchly’s sphericity test, the 100 µM folate group was
found to be significantly higher than the control group (P < 0.05).
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Figure 2. Pemetrexed (folic acid metabolism inhibitor) effect. PTX (0.25–20 µM, low dose effect; 125 µM–2.5 mM,
high dose effect) cell proliferations were measured in real time for 7 h. A nontoxic dose was selected for HUVECs for
combined effect. When the trend change between recurrent measurements was analyzed using Mauchly’s sphericity
test, the 5 and 2.5 mM PTX groups were significantly higher than the control group (P < 0.05).

Figure 3. Folic acid + MSC-derived soluble factor effect. Folic acid (2.5–100 µM) was added to the bottom chamber in the coculture
medium + 50 µL mesenchymal stem cell culture medium at each concentration; cell proliferation was measured in real time for 48 h at
7 concentrations. The trend change between repeating measurements was analyzed using Mauchly’s sphericity test (P < 0.05).
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Figure 4. Folic acid effect in the HUVEC wound healing model. The effect of folic acid with PTX and MTX on cells was monitored for 24 h. A) Real-time images of wound healing; B) wound closure rates are given as percentage motility index. t: Folic acid
group against control; *: MTX against folic acid group; &: PTX against folic acid group.

4. Discussion
This study investigated the role of folic acid on regeneration
in vascular tissue and the healing ability of different
soluble factors associated with MSCs on wound healing.
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The results show that MDFs have an enhancing effect on
cell proliferation and migration. Folic acid also increases
the proliferation of vascular endothelial cells and induces
the repair of vascular damage.
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Figure 5. The effect of mesenchymal stem cells in the HUVEC wound healing model. MDFs, folic acid, and folic acid with MDFs in
the coculture model wound healing effects were monitored for 24 h. A) Real-time images of wound healing; B) wound closure rates. t:
Folic acid group against MDFs; *: folate + MDFs group against MDFs.

919

PAKDEMİRLİ et al. / Turk J Med Sci
The presence of PMX and MTX, an antagonist and
an inhibitor of folic acid, limit the proliferation and the
wound healing. These data also support that folic acid has
a role in the regeneration.
According to the results of this study, the effect of folic
acid on the proliferation and wound healing in vascular
endothelial cells decreases in the presence of folic acid
antagonists and inhibitors. This indicates that folic acid is
effective in improving endothelial damage.
There is a considerable impact on epidermal cells’
migration and mitotic division rates during wound healing.
It was suggested that epidermal repair in wound healing
is affected by the movement of epidermal cells over each
other upon the surface of the wound [16]. Folic acid is also
known to be essential for DNA synthesis and repair [17].
The folic acid may be reduced to active tetrahydrofolic
acid in response to folic acid reductase in vivo. Since
tetrahydrofolic acid is the main carrier of a carbon unit and
plays a role in the synthesis of purine and pyrimidine and
in the mutual transformation of amino acids, lack of this
vitamin in vivo may impair the transmission of a carbon
unit and affect the nucleic acid synthesis and amino acid
metabolism necessary for cell proliferation, tissue growth,
and development. Therefore, folic acid plays a critical role
in the development of proliferation and differentiation of
stem cells [14]. The presence of folic acid in cell division

during wound healing increased the rate of healing due to
its increasing effect on cell division.
Regeneration procedures in wound healing normally
occur through the extracellular matrix and are caused by
complex interactions between cells and paracrine factors.
When the effect of paracrine factors secreted by BMMSCs on wound healing was examined by Chen et al.
[18], it was observed that the cells had healing effects. The
coculture model and MSC-derived secretory factors have
been shown to increase the effect of wound healing on cell
migration by the paracrine effect. The content of MDFs
will be important in this context.
In addition, it was determined that the combined
application was more effective than stem cell injection
and folic acid in individual applications. Heseker noted
that supplementation with folic acid significantly reduces
the risk of neural tube defects and helps with healing. The
results of this study confirm this research [19].
This study’s results are proven to be accurate for the in
vitro wound healing model. It serves as a contribution to
the literature on in vivo (phase 0) studies.
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